Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06640413
Title A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination with L19-IL2 As a Treatment of Metastatic FAP-positive Solid Tumors (Theratri)
Acronym Theratri
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Philogen S.p.A.
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.